Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES.

BACKGROUND AND OBJECTIVES Sufficiently powered studies to investigate the CKD prevalence are few and do not cover southern Europe. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS For the INCIPE study, 6200 Caucasian patients ≥40 years old were randomly selected in northeastern Italy in 2006. Laboratory determinations were centralized. The albumin to creatinine ratio in urine and estimated GFR from calibrated creatinine (SCr) were determined. A comparison with 2001 through 2006 NHANES surveys was performed. RESULTS Prevalence of CKD was 13.2% in northeastern (NE) Italy (age and gender standardized to the U.S. 2007 Caucasian population). Prevalence of CKD in U.S. Caucasians is higher (20.3%), the major difference being in CKD 3. Risk factors for CKD are more prevalent in the United States than in Italy. With use of CKD 3a and 3b stages, CKD prevalence decreased in NE Italy (8.5%) and in the United States (12.8%). CONCLUSIONS The prevalence of CKD is high in NE Italy, but lower than that in the United States. A large part of the difference in CKD prevalence in NE Italy versus that in the United States is due to the different prevalence of CKD 3. The higher prevalence of a number of renal risk factors in persons from the United States explains in part the different dimensions of the CKD problem in the two populations.

[1]  C. Winearls,et al.  An epidemic of chronic kidney disease: fact or fiction? , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  C. Zoccali,et al.  Screening for chronic kidney disease: where does Europe go? , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[4]  C. McCulloch,et al.  Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. , 2002, Journal of the American Society of Nephrology : JASN.

[5]  B. Astor,et al.  Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. , 2007, Archives of internal medicine.

[6]  G. Gambaro,et al.  Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  M. Cirillo.  Evaluation of glomerular filtration rate and of albuminuria/proteinuria. , 2010, Journal of nephrology.

[8]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[10]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[11]  A. Rule,et al.  Can we do better than a single estimated GFR threshold when screening for chronic kidney disease? , 2007, Kidney international.

[12]  J. Coresh,et al.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[14]  N. Powe,et al.  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[16]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Gansevoort,et al.  Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[19]  L. Kiemeney,et al.  Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. , 2007, Kidney international.

[20]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome , 2005 .

[21]  D. Levy,et al.  Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. , 2007, Archives of internal medicine.

[22]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[23]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  D. de Zeeuw,et al.  The kidney, a cardiovascular risk marker, and a new target for therapy. , 2005, Kidney international. Supplement.